{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:03:07Z","timestamp":1791378187119,"version":"4.3.2"},"reference-count":92,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jinf.2024.106125","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T11:18:54Z","timestamp":1708168734000},"page":"106125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Bacteriophage therapy and current delivery strategies for orthopedic infections: A SCOPING review"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9718-1797","authenticated-orcid":false,"given":"Jason","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1385-9805","authenticated-orcid":false,"given":"Sang W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad J.","family":"Shariyate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Wixted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ara","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher F.","family":"Rowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward K.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jinf.2024.106125_bib1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.arth.2015.01.017","article-title":"Medicare reimbursement attributable to periprosthetic joint infection following primary hip and knee arthroplasty","volume":"30","author":"Yi","year":"2015","journal-title":"J Arthroplast"},{"issue":"23 Suppl","key":"10.1016\/j.jinf.2024.106125_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.5435\/JAAOS-D-14-00394","article-title":"The economic significance of orthopaedic infections","author":"Hackett","year":"2015","journal-title":"J Am Acad Orthop Surg"},{"issue":"2 Suppl","key":"10.1016\/j.jinf.2024.106125_bib3","article-title":"Orthopaedic infections: what have we learned?","volume":"6","author":"Lee","year":"2023","journal-title":"OTA Int"},{"issue":"4","key":"10.1016\/j.jinf.2024.106125_bib4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jcot.2015.04.004","article-title":"Surgical site infection in orthopedic trauma: a case-control study evaluating risk factors and cost","volume":"6","author":"Thakore","year":"2015","journal-title":"J Clin Orthop Trauma"},{"issue":"2","key":"10.1016\/j.jinf.2024.106125_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/17453674.2014.966290","article-title":"The role of microbial biofilms in prosthetic joint infections: a review","volume":"86","author":"Gbejuade","year":"2015","journal-title":"Acta Orthop"},{"issue":"2","key":"10.1016\/j.jinf.2024.106125_bib6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.00111-13","article-title":"Prosthetic joint infection","volume":"27","author":"Tande","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.jinf.2024.106125_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0040-1701214","article-title":"Biofilms in periprosthetic joint infections: a review of diagnostic modalities, current treatments, and future directions","volume":"33","author":"Shoji","year":"2020","journal-title":"J Knee Surg"},{"issue":"8","key":"10.1016\/j.jinf.2024.106125_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5194\/jbji-6-379-2021","article-title":"Long-term outcome of two-stage revision surgery after hip and knee prosthetic joint infections: an observational study","volume":"6","author":"Bourgonjen","year":"2021","journal-title":"J Bone Jt Infect"},{"issue":"4","key":"10.1016\/j.jinf.2024.106125_bib9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2106\/JBJS.20.00550","article-title":"Direct inpatient medical costs of operative treatment of periprosthetic hip and knee infections","volume":"103","author":"Yao","year":"2021","journal-title":"J Bone Jt Surg Am"},{"issue":"10","key":"10.1016\/j.jinf.2024.106125_bib10","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"Peters","year":"2020","journal-title":"JBI Evid Synth"},{"issue":"7","key":"10.1016\/j.jinf.2024.106125_bib11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.jinf.2024.106125_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jhmas\/jry024","article-title":"An alternative cure: the adoption and survival of bacteriophage therapy in the USSR, 1922\u20131955","volume":"73","author":"Myelnikov","year":"2018","journal-title":"J Hist Med Allied Sci"},{"key":"10.1016\/j.jinf.2024.106125_bib13","unstructured":"Appendix 11.1 JBI template source of evidence details, characteristics and results extraction instrument - JBI Manual for Evidence Synthesis - JBI Global Wiki [Internet]. [cited 2023 Aug 14]. Available from: \u3008https:\/\/jbi-global-wiki.refined.site\/space\/MANUAL\/4687579\/Appendix+11.1+JBI+template+source+of+evidence+details%2C+characteristics+and+results+extraction+instrument\u3009."},{"issue":"9","key":"10.1016\/j.jinf.2024.106125_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa389","article-title":"Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States","volume":"7","author":"Aslam","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jinf.2024.106125_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.02127","article-title":"Bacteriophage ZCKP1: a potential treatment for klebsiella pneumoniae isolated from diabetic foot patients","author":"Taha","year":"2018","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.jinf.2024.106125_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01736-21","article-title":"Bacteriophage therapy for the prevention and treatment of fracture-related infection caused by Staphylococcus aureus: a preclinical study","volume":"9","author":"Onsea","year":"2021","journal-title":"Microbiol Spectr"},{"issue":"12","key":"10.1016\/j.jinf.2024.106125_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226574","article-title":"Evaluation of bacteriophage as an adjunct therapy for treatment of peri-prosthetic joint infection caused by Staphylococcus aureus","volume":"14","author":"Morris","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jinf.2024.106125_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/0971-5916.178615","article-title":"Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model","volume":"143","author":"Kishor","year":"2016","journal-title":"Indian J Med Res"},{"issue":"1","key":"10.1016\/j.jinf.2024.106125_bib19","doi-asserted-by":"crossref","first-page":"E144","DOI":"10.1093\/cid\/ciaa705","article-title":"Phage therapy for limb-threatening prosthetic knee klebsiella pneumoniae infection: case report and in vitro characterization of anti-biofilm activity","volume":"73","author":"Cano","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2024.106125_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ph14030231","article-title":"Successful treatment of a recalcitrant Staphylococcus epidermidis prosthetic knee infection with intraoperative bacteriophage therapy","volume":"14","author":"Doub","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.jinf.2024.106125_bib21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/antibiotics11050616","article-title":"Salphage: salvage bacteriophage therapy for recalcitrant MRSA prosthetic joint infection","volume":"11","author":"Doub","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jinf.2024.106125_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2023.e01854","article-title":"Salphage: Salvage bacteriophage therapy for a chronic Enterococcus faecalis prosthetic joint infection","volume":"33","author":"Doub","year":"2023","journal-title":"IDCases"},{"issue":"5","key":"10.1016\/j.jinf.2024.106125_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics9050241","article-title":"Salvage Bacteriophage Therapy for a Chronic MRSA Prosthetic Joint Infection","volume":"9","author":"Doub","year":"2020","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.jinf.2024.106125_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad051","article-title":"Application of phage therapy in a case of a chronic hip-prosthetic joint infection due to pseudomonas aeruginosa: an Italian real-life experience and in vitro analysis","volume":"10","author":"Cesta","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2024.106125_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/ph15020177","article-title":"Successful use of salvage bacteriophage therapy for a recalcitrant MRSA knee and hip prosthetic joint infection","volume":"15","author":"Schoeffel","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.jinf.2024.106125_bib26","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.medj.2023.07.002","article-title":"Refractory Pseudomonas aeruginosa infections treated with phage PASA16: a compassionate use case series","volume":"4","author":"Onallah","year":"2023","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.jinf.2024.106125_bib27","doi-asserted-by":"crossref","first-page":"E1463","DOI":"10.1093\/cid\/ciac694","article-title":"Experience using adjuvant bacteriophage therapy for the treatment of 10 recalcitrant periprosthetic joint infections: a case series","volume":"76","author":"Doub","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2024.106125_bib28","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2340\/17453674.2022.4579","article-title":"Salphage: salvage bacteriophage therapy for a recalcitrant Klebsiella pneumoniae prosthetic shoulder infection - a case report","volume":"93","author":"Doub","year":"2022","journal-title":"Acta Orthop [Internet]"},{"issue":"6","key":"10.1016\/j.jinf.2024.106125_bib29","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3390\/v13061182","article-title":"Successful treatment of Staphylococcus aureus prosthetic joint infection with bacteriophage therapy","volume":"13","author":"Ramirez-Sanchez","year":"2021","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.jinf.2024.106125_bib30","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1080\/17453674.2021.1968714","article-title":"Bacteriophage therapy cures a recurrent Enterococcus faecalis infected total hip arthroplasty? A case report","volume":"92","author":"Neuts","year":"2021","journal-title":"Acta Orthop"},{"key":"10.1016\/j.jinf.2024.106125_bib31","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.12968\/jowc.2016.25.7.S27","article-title":"Bacteriophage treatment of intransigent Diabetic toe ulcers: A case series","volume":"25","author":"Fish","year":"2016","journal-title":"J Wound Care"},{"issue":"3","key":"10.1016\/j.jinf.2024.106125_bib32","first-page":"158","article-title":"Bacteriophage therapy as a potential management option for surgical wound infections","volume":"1","author":"Nadareishvili","year":"2020","journal-title":"Phage (New Rochelle)"},{"issue":"8","key":"10.1016\/j.jinf.2024.106125_bib33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.clinthera.2023.06.009","article-title":"Phage therapy for diabetic foot infection: a case series","volume":"45","author":"Young","year":"2023","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.jinf.2024.106125_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad221","article-title":"Compassionate use of bacteriophages for failed persistent infections during the first 5 years of the israeli phage therapy center","volume":"10","author":"Onallah","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2024.106125_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/antibiotics7040087","article-title":"Resolving digital staphylococcal osteomyelitis using bacteriophage-a case report","volume":"7","author":"Fish","year":"2018","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jinf.2024.106125_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-4939-7395-8_14","article-title":"Compassionate use of bacteriophage therapy for foot ulcer treatment as an effective step for moving toward clinical trials","author":"Fish","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"11","key":"10.1016\/j.jinf.2024.106125_bib37","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/cid\/ciz222","article-title":"Successful treatment of antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics combination","volume":"69","author":"Nir-Paz","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2024.106125_bib38","article-title":"Use of phage cocktail BFC 1.10 in combination with ceftazidime-avibactam in the treatment of multidrug-resistant pseudomonas aeruginosa femur osteomyelitis\u2014a case report","volume":"9","author":"Racenis","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.jinf.2024.106125_bib39","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41467-021-27656-z","article-title":"Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae","volume":"13","author":"Eskenazi","year":"2022","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.jinf.2024.106125_bib40","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202113936","article-title":"Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child","volume":"13","author":"Khatami","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.jinf.2024.106125_bib41","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1038\/s41467-022-31837-9","article-title":"Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection","volume":"13","author":"Ferry","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.jinf.2024.106125_bib42","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1093\/jac\/dky263","article-title":"Innovations for the treatment of a complex bone and joint infection due to XDR Pseudomonas aeruginosa including local application of a selected cocktail of bacteriophages","volume":"73","author":"Ferry","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.jinf.2024.106125_bib43","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3390\/v13101898","article-title":"A case of in situ phage therapy against Staphylococcus aureus in a bone allograft polymicrobial biofilm infection: outcomes and phage-antibiotic interactions","volume":"13","author":"Van Nieuwenhuyse","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jinf.2024.106125_bib44","article-title":"Case report: arthroscopic \u201cDebridement Antibiotics and Implant Retention\u201d with local injection of personalized phage therapy to salvage a relapsing pseudomonas aeruginosa prosthetic knee infection","volume":"8","author":"Ferry","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"10.1016\/j.jinf.2024.106125_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy269","article-title":"Salvage Debridement, Antibiotics And Implant Retention (\u201cDAIR\u201d) with local injection of a selected cocktail of bacteriophages: is it an option for an elderly patient with relapsing Staphylococcus aureus prosthetic-joint infection?","volume":"5","author":"Ferry","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2024.106125_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00924-19","article-title":"Bacteriophages as adjuvant to antibiotics for the treatment of periprosthetic joint infection caused by multidrug-resistant pseudomonas aeruginosa","volume":"64","author":"Tkhilaishvili","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2024.106125_bib47","article-title":"Phage therapy as adjuvant to conservative surgery and antibiotics to salvage patients with relapsing S. aureus prosthetic knee infection","volume":"7","author":"Ferry","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"10.1016\/j.jinf.2024.106125_bib48","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3390\/v11100891","article-title":"Bacteriophage application for difficult-to-treat musculoskeletal infections: development of a standardized multidisciplinary treatment protocol","volume":"11","author":"Onsea","year":"2019","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.jinf.2024.106125_bib49","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41564-019-0634-z","article-title":"Safety of bacteriophage therapy in severe Staphylococcus aureus infection","volume":"5","author":"Petrovic Fabijan","year":"2020","journal-title":"Nat Microbiol"},{"issue":"2","key":"10.1016\/j.jinf.2024.106125_bib50","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3390\/v15020499","article-title":"Short-term outcomes of phage-antibiotic combination treatment in adult patients with periprosthetic hip joint infection","volume":"15","author":"Fedorov","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jinf.2024.106125_bib51","article-title":"Pharmacokinetic assessment of staphylococcal phage K following parenteral and intra-articular administration in rabbits","volume":"13","author":"Totten","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jinf.2024.106125_bib52","doi-asserted-by":"crossref","first-page":"14514","DOI":"10.3390\/ijms232314514","article-title":"Phage-based control of methicillin resistant Staphylococcus aureus in a galleria mellonella model of implant-associated infection","volume":"23","author":"Materazzi","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jinf.2024.106125_bib53","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4161\/bact.1.1.13980","article-title":"Lysis from without","volume":"1","author":"Abedon","year":"2011","journal-title":"Bacteriophage"},{"issue":"3\u20134","key":"10.1016\/j.jinf.2024.106125_bib54","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0022-5320(64)80011-3","article-title":"Electron microscopy of lysis from without of Escherichia coli B by coliphage T2","volume":"10","author":"Cota-Robles","year":"1964","journal-title":"J Ultrastruct Res"},{"issue":"5","key":"10.1016\/j.jinf.2024.106125_bib55","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1085\/jgp.23.5.643","article-title":"The growth of bacteriophage and lysis of the host","volume":"23","author":"Delbr\u00fcck","year":"1940","journal-title":"J Gen Physiol"},{"issue":"1","key":"10.1016\/j.jinf.2024.106125_bib56","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1089\/sur.2018.135","article-title":"Evaluation of bacteriophage anti-biofilm activity for potential control of orthopedic implant-related infections caused by Staphylococcus aureus","volume":"20","author":"Morris","year":"2019","journal-title":"Surg Infect (Larchmt)"},{"issue":"3","key":"10.1016\/j.jinf.2024.106125_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04918-22","article-title":"Optimization of phage-antibiotic combinations against Staphylococcus aureus biofilms","volume":"11","author":"Kebriaei","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jinf.2024.106125_bib58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.22203\/eCM.v043a07","article-title":"Microbiological and ultrastructural evaluation of bacteriophage 191219 against planktonic, intracellular and biofilm infection with Staphylococcus aureus","volume":"43","author":"Mannala","year":"2022","journal-title":"Eur Cell Mater"},{"issue":"3","key":"10.1016\/j.jinf.2024.106125_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02231-19","article-title":"Evaluation of the activity of a combination of three bacteriophages alone or in association with antibiotics on Staphylococcus aureus embedded in biofilm or internalized in osteoblasts","volume":"64","author":"Kolenda","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2024.106125_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090411","article-title":"Bacteriophage mediated killing of Staphylococcus aureus in vitro on orthopaedic K wires in presence of linezolid prevents implant colonization","volume":"9","author":"Kaur","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2024.106125_bib61","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/v11010018","article-title":"Clinical indications and compassionate use of phage therapy: personal experience and literature review with a focus on osteoarticular infections","volume":"Vol 11","author":"Patey","year":"2019","journal-title":"Viruses"},{"issue":"FEB","key":"10.1016\/j.jinf.2024.106125_bib62","first-page":"74029","article-title":"The factors affecting effectiveness of treatment in phages therapy","volume":"5","author":"Ly-Chatain","year":"2014","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.jinf.2024.106125_bib63","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01879-21","article-title":"Phage activity against planktonic and biofilm staphylococcus aureus periprosthetic joint infection isolates","volume":"66","author":"Totten","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.jinf.2024.106125_bib64","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2106\/JBJS.21.00958","article-title":"Assessment of Staphylococcal clinical isolates from periprosthetic joint infections for potential bacteriophage therapy","volume":"104","author":"Depalma","year":"2022","journal-title":"J Bone Jt Surg"},{"issue":"4","key":"10.1016\/j.jinf.2024.106125_bib65","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10238-009-0044-2","article-title":"A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses","volume":"9","author":"Mi\u0229dzybrodzki","year":"2009","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jinf.2024.106125_bib66","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.copbio.2020.11.011","article-title":"Phage-specific antibodies","volume":"68","author":"Gembara","year":"2021","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"10.1016\/j.jinf.2024.106125_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01359-23","article-title":"Evaluation of the impact of repeated intravenous phage doses on mammalian host\u2013phage interactions","volume":"98","author":"Tan","year":"2023","journal-title":"J Virol"},{"key":"10.1016\/j.jinf.2024.106125_bib68","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.3389\/fimmu.2019.02607","article-title":"Induction of phage-specific antibodies by two therapeutic Staphylococcal bacteriophages administered per os","volume":"10","author":"Majewska","year":"2019","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.jinf.2024.106125_bib69","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.3390\/v7082845","article-title":"Oral application of T4 phage induces weak antibody production in the gut and in the blood","volume":"7","author":"Majewska","year":"2015","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.jinf.2024.106125_bib70","first-page":"1","article-title":"Adjunctive use of phage Sb-1 in antibiotics enhances inhibitory biofilm growth activity versus rifampin-resistant Staphylococcus aureus strains","volume":"9","author":"Wang","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"10.1016\/j.jinf.2024.106125_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/v15020460","article-title":"Phage and antibiotic combinations reduce staphylococcus aureus in static and dynamic biofilms grown on an implant material","volume":"15","author":"Joo","year":"2023","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.jinf.2024.106125_bib72","article-title":"Evaluation of Staphylococcal bacteriophage Sb-1 as an adjunctive agent to antibiotics against rifampin-resistant Staphylococcus aureus biofilms","volume":"11","author":"Wang","year":"2020","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.jinf.2024.106125_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157626","article-title":"In vivo assessment of phage and linezolid based implant coatings for treatment of methicillin resistant S. aureus (MRSA) mediated orthopaedic device related infections","volume":"11","author":"Kaur","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jinf.2024.106125_bib74","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2106\/JBJS.K.01135","article-title":"Bacteriophage therapy in implant-related infections: an experimental study","volume":"95","author":"Yilmaz","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jinf.2024.106125_bib75","doi-asserted-by":"crossref","first-page":"1134912","DOI":"10.3389\/fmed.2023.1134912","article-title":"Combining bacteriophage and vancomycin is efficacious against MRSA biofilm-like aggregates formed in synovial fluid","volume":"10","author":"Taha","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.jinf.2024.106125_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106200","article-title":"Bacteriophage-antibiotic combinations against ciprofloxacin\/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model","volume":"56","author":"Wang","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"10.1016\/j.jinf.2024.106125_bib77","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s10856-012-4711-6","article-title":"New antibacterial microporous CaP materials loaded with phages for prophylactic treatment in bone surgery","volume":"23","author":"Meurice","year":"2012","journal-title":"J Mater Sci Mater Med"},{"key":"10.1016\/j.jinf.2024.106125_bib78","first-page":"111","article-title":"3D printed bioceramic for phage therapy against bone nosocomial infections","author":"Bouchart","year":"2020","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"12","key":"10.1016\/j.jinf.2024.106125_bib79","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.1021\/acsapm.1c01057","article-title":"Poly(ethyleneimine)\/Poly(acrylic acid) multilayer coatings with peripherally bound Staphylococcus aureus bacteriophages have antibacterial properties","volume":"3","author":"M\u00fcller","year":"2021","journal-title":"ACS Appl Polym Mater"},{"issue":"9","key":"10.1016\/j.jinf.2024.106125_bib80","first-page":"1","article-title":"A localized phage-based antimicrobial system: effect of alginate on phage desorption from \u03b2-TCP ceramic bone substitutes","volume":"9","author":"Ismail","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jinf.2024.106125_bib81","article-title":"Alginate chitosan microbeads and thermos-responsive hyaluronic acid hydrogel for phage delivery","volume":"79","author":"Rotman","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"10.1016\/j.jinf.2024.106125_bib82","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jbm.a.36790","article-title":"Bacteriophage delivering hydrogels reduce biofilm formation in vitro and infection in vivo","volume":"108","author":"Wroe","year":"2020","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.jinf.2024.106125_bib83","article-title":"Encapsulated bacteriophages in alginate-nanohydroxyapatite hydrogel as a novel delivery system to prevent orthopedic implant-associated infections","volume":"24","author":"Barros","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jinf.2024.106125_bib84","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fmed.2020.00342","article-title":"The potential innovative use of bacteriophages within the DAC\u00ae hydrogel to treat patients with knee megaprosthesis infection requiring \u201cDebridement Antibiotics and Implant Retention\u201d and soft tissue coverage as salvage therapy","volume":"7","author":"Ferry","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.jinf.2024.106125_bib85","article-title":"Human plasma significantly reduces bacteriophage infectivity against Staphylococcus aureus clinical isolates","volume":"14","author":"Shinde","year":"2022","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.jinf.2024.106125_bib86","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41579-022-00686-0","article-title":"Skeletal infections: microbial pathogenesis, immunity and clinical management","volume":"20","author":"Masters","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jinf.2024.106125_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.937466","article-title":"Osteocytes serve as a reservoir for intracellular persisting Staphylococcus aureus due to the lack of defense mechanisms","volume":"13","author":"Garcia-Moreno","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jinf.2024.106125_bib88","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijid.2022.03.022","article-title":"Impact of bacterial phenotypic variation with bacteriophage therapy: a pilot study with prosthetic joint infection isolates","volume":"119","author":"Doub","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2024.106125_bib89","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s15010-021-01675-w","article-title":"Observed transaminitis with a unique bacteriophage therapy protocol to treat recalcitrant Staphylococcal biofilm infections","volume":"50","author":"Doub","year":"2022","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.jinf.2024.106125_bib90","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/jebm.12266","article-title":"Grey literature: an important resource in systematic reviews","volume":"10","author":"Paez","year":"2017","journal-title":"J Evid Based Med"},{"key":"10.1016\/j.jinf.2024.106125_bib91","unstructured":"Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR. - Full Text View - ClinicalTrials.gov [Internet]. [cited 2023 Oct 4]. Available from: \u3008https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05369104?term=bacteriophage+prosthetic+joint+infection&draw=2&rank=4\u3009."},{"key":"10.1016\/j.jinf.2024.106125_bib92","unstructured":"Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI) - Full Text View - ClinicalTrials.gov [Internet]. [cited 2023 Oct 4]. Available from: \u3008https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05269134?term=bacteriophage+prosthetic+joint+infection&draw=2&rank=2\u3009."}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324000598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324000598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:38:30Z","timestamp":1759009110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445324000598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0163445324000598"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106125","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacteriophage therapy and current delivery strategies for orthopedic infections: A SCOPING review","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106125"}}